| Name | 1-[1-[4-(1-acetylpiperidin-4-yl)oxy-2-methoxybenzoyl]piperidin-4-yl]-4H-3,1-benzoxazin-2-one |
|---|---|
| Synonyms | l-371,257 |
| Description | L-371,257 is an orally bioavailable, selective and competitive antagonist of oxytocin receptor (pA2=8.4) with high affinity at both the oxytocin receptor (Ki=19 nM) and vasopressin V1a receptor (Ki=3.7 nM)[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 19 nM (oxytocin receptor), 3.7 nM (vasopressin V1a receptor)[2] |
| References |
| Molecular Formula | C28H33N3O6 |
|---|---|
| Molecular Weight | 507.58 |
| Exact Mass | 507.23700 |
| PSA | 88.62000 |
| LogP | 3.78710 |
| Storage condition | -20°C |